US45258D1054
US45258D1054
Immunocore Holdings plc
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 400.016.000 | 310.202.000 | 29.0% |
| Cost of Revenue | 5.087.000 | 2.731.000 | 86.3% |
| Gross Profit | 394.929.000 | 307.471.000 | 28.4% |
| 440.282.000 | 377.932.000 | 16.5% | |
| Operating Income | -45.353.000 | -70.461.000 | 35.6% |
| Pretax Income | -19.100.000 | -52.937.000 | 63.9% |
| Net Income Common Stockholders | -35.514.000 | -51.087.000 | 30.5% |
| -- | -- | -- | |
| -- | -- | -- |